about
Top-down proteomics in health and disease: challenges and opportunitiesEvaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical useQuantitative mass spectrometry evaluation of human retinol binding protein 4 and related variantsThe use of bioreactive probes in protein characterization.Efficient sample preparation in immuno-matrix-assisted laser desorption/ionization mass spectrometry using acoustic trapping.Advances in surface plasmon resonance biomolecular interaction analysis mass spectrometry (BIA/MS).Recent trends in protein biochip technology.Use of nitrocellulose films for affinity-directed mass spectrometry for the analysis of antibody/antigen interactions.Surface mass spectrometry of molecular species.Detection of novel truncated forms of human serum amyloid A protein in human plasma.Epitope mapping of monoclonal antibodies by mass spectrometry: identification of protein antigens in complex biological systems.Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins.Isotope-differentiated binding energy shift tags (IDBEST) for improved targeted biomarker discovery and validation.A computer algorithm for the identification of protein interactions from the spectra of masses (PRISM).Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigensAn immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis.Dependence of the ejection velocities of laser-ablated ions on the laser wavelength and fluence.Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins within complex biofluids.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesBiochips that sequentially capture and focus antigens for immunoaffinity MALDI-TOF MS: a new tool for biomarker verificationMALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics.C-peptide microheterogeneity in type 2 diabetes populations.Delineation of concentration ranges and longitudinal changes of human plasma protein variants.Lab-on-a-plate: extending the functionality of MALDI-MS and LDI-MS targets.Investigating diversity in human plasma proteinsContributions of mass spectrometry to structural immunology.Recent application of analytical methods to phase I and phase II drugs development: a review.Mass spectrometric immunoassay revisitedGold patterned biochips for on-chip immuno-MALDI-TOF MS: SPR imaging coupled multi-protein MS analysis.Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry.Mass spectrometry-based protein assays for in vitro diagnostic testing.Mass-spectrometry-based clinical proteomics--a review and prospective.Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF)On-target and nanoparticle-facilitated selective enrichment of peptides and proteins for analysis by MALDI-MS.Targeted quantitative mass spectrometric immunoassay for human protein variants.Serum amyloid a truncations in type 2 diabetes mellitus.Recent methodological advances in MALDI mass spectrometry.Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.
P2860
Q27002139-D710B7FC-7DC2-46E7-9CEC-80E34CB67FF7Q28652076-6C38627E-6EC9-4866-B5EF-26616021B9DBQ28741516-DFA13F03-03FC-4480-BD63-C70AB73E911DQ30431252-DE12F150-4B53-4CE1-926F-4C639706BDCEQ30441133-E443370C-1FAB-4305-9D5A-8AB0E75B0FF3Q30632225-0AA3106C-3376-4308-891E-A9E5BDBD7868Q30659509-AA71F006-0C65-49A8-8B1B-98094DBD6BFDQ30717232-7665CA33-EC3B-49C6-B80D-FF8CA08DDB3FQ30735260-437466BD-8751-460C-9BC4-BC6EC8B6921CQ31133257-94F2E1B8-1231-4B0A-BE84-78427000E64DQ31939448-B9811C32-B0CC-4BDF-ABBF-E44215BA5219Q33185913-BF26D07C-6BEA-4C13-929A-A30C5BC75720Q33217472-7965DA08-BD11-4BCC-B379-9DB2AE801E9DQ33266178-2AECC16A-B409-4B47-B076-C4075ACC4E3AQ33289397-F4BA2CFE-5418-47A9-8A0A-FD99F3A78055Q33306208-950C3978-DDFD-45C8-9468-044E6B5811D8Q33441189-F3251A2C-BB45-42CA-88A8-23AA9ECFAE09Q33622969-252502C2-250A-4393-A6F1-E74C9B5FAABEQ33643266-93B2AB62-431C-4766-B19A-D499AEC5A3F5Q33722303-6A28A920-179F-4889-B5A2-348F6F0AB63EQ33747200-E70A10CB-651C-4C1D-9984-B3AC3F73E5CEQ33764455-1C4A2D8D-B109-479A-8853-F827D681DD1AQ33793513-695375D4-1849-4191-AFC6-867E289C030CQ33799571-87052AC6-4C23-40F6-8095-936B7B000721Q33905685-5F94B566-A1B2-49C8-8C7E-FF4AADFC47C6Q33910650-5484CC48-EAD7-4B77-A5C3-4F38D7D812B7Q33997398-D9DDD7BA-FC92-46B3-88E2-8309B7629476Q34033095-20CD2155-1F2D-4780-AFC3-4B3F5391629CQ34075780-9AAD7BEA-61A2-4C0B-BF67-42346482F2B0Q34075986-C6349D37-55A3-472F-88C1-565E53938613Q34216869-6B091945-938E-4863-8C7B-6F80B551C3D8Q34252113-865A8962-D4E6-415E-B171-C99F054F18D0Q34362934-4B7C962C-0285-4666-9834-6D2FAA585480Q34466472-F5725540-8D4D-4CB4-8075-C50DB402261EQ34825391-AB03F268-FBB4-4A98-B8A6-338457FB87BFQ34995355-06852E6E-B3FD-49D2-A1FE-8B611D74CA9BQ35126789-54C31947-2456-4FDB-8C99-143E8421332BQ35130223-F0E94B0E-B11E-48EA-B1DE-4D3F3D43F9ADQ35166976-07B18401-4D11-47BA-9403-F5FD003534C1Q35264312-C8E9A3A2-680A-4BD7-B2DB-A626F31614AB
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Mass spectrometric immunoassay.
@ast
Mass spectrometric immunoassay.
@en
type
label
Mass spectrometric immunoassay.
@ast
Mass spectrometric immunoassay.
@en
prefLabel
Mass spectrometric immunoassay.
@ast
Mass spectrometric immunoassay.
@en
P2093
P356
P1433
P1476
Mass spectrometric immunoassay.
@en
P2093
P304
P356
10.1021/AC00103A003
P407
P577
1995-04-01T00:00:00Z